glp 1 agonist novo nordisk Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Novo Nordisk expands patient access

Compounded tirzepatide then naturally seems like a realistic option

You may still be a candidate for the Fitish Microdosing program, a lower dose option for patients who want a gentler, cosmetic approach

Learn approved sites, rotation techniques, and common mistakes to optimise your GLP-1 treatment safely and effectively.

Personalized treatment across 120+ conditions.

What you get: Live Akkermansia muciniphila the keystone gut strain associated with gut barrier integrity, microbiome diversity and the gut environment that helps support healthy appetite signalling, available live from the only brand that has solved the stability challenge